-
Featured
Identifying Risk Factors for Type 2 Myocardial Infarction
In one of the first large systematic surveys of the frequency and implications of supply/demand-related Type 2 Myocardial Infarction, a suite of risk factors has been identified to help ensure patients receive proper care.
-
Featured
Novel Therapeutic May Prevent Mitral Valve Damage After Heart Attack
Damage to the mitral valve after heart attack leads to HF and death. Treatment with hypertension drug may reduce mitral valve scaring and stiffening.
-
Featured
DNA is not Destiny When it Comes to Heart Attack Risk
A study led by Sekar Kathiresan, MD, of Mass General, has found that having a favorable lifestyle can help those with a high genetic risk of having a heart attack reduce their risk by over 50%.
-
Biomarkers and Heart Failure
In this video, Hanna Gaggin, MD, MPH, discusses her research in discovering biomarkers of patients with preserved ejection fraction. She hopes that more progress will be made in finding treatment options for patients with type 2 myocardial infarction.
-
Extremely Sensitive Troponin Assay Predicts Impending Cardiovascular Events in Patients with Stable Chest Pain
Data from the PROMISE trial suggest that a "single-molecule counting" troponin assay might someday allow office-based assessment of which patients with stable chest pain are at short-term risk of major cardiovascular events and need aggressive diagnostic evaluation.
-
ACC Provides Guidance to Cardiologists on Using SGLT2 Inhibitors and GLP-1RAs
A new Expert Consensus Decision Pathway from the American College of Cardiology urges cardiologists to consider sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists for all patients with type 2 diabetes who have atherosclerotic cardiovascular disease.
Myocardial Infarction contributors
-
Hanna K. Gaggin, MD, MPH
Assistant Physician, Massachusetts General Hospital, Assistant Professor, Harvard Medical School
Recent Article
Biomarkers and Heart Failure
-
James Louis Januzzi, MD
Hutter Family Professor of Medicine, Director, Dennis and Marilyn Barry Fellowship in Cardiology Research
Recent Article
Dual-Biomarker Strategy Helps Identify Nonresponders to Cardiac Resynchronization
-
Pradeep Natarajan, MD, MMSc
Director, Preventive Cardiology, Instructor of Medicine, Harvard Medical School
Recent Article
What Is Your New Year's Resolution?
-
Sekar Kathiresan, MD
Director of the Center for Genomic Medicine , Ofer and Shelley Nemirovsky MGH Research Scholar, Director of the Cardiovascular Disease Initiative at the Broad institute
Recent Article
Leveraging Social Media in Medicine
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.Resource links
